US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gelteq

1.56

0.0000

Post-market: 1.48-0.0800-5.13%19:52 EDT

Volume:1.68M

Turnover:2.31M

Market Cap:15.64M

PE:-4.08

High:1.62

Open:1.29

Low:1.22

Close:1.56

52wk High:5.50

52wk Low:0.7701

Shares:10.03M

Float Shares:4.64M

Volume Ratio:0.12

T/O Rate:36.21%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.3819

EPS(LYR):-0.2915

ROE:-21.00%

ROA:-8.04%

PB:1.26

PE(LYR):-5.35

Loading ...

Overview Company News Filings

3 Penny Stocks to Watch Now, 9/8/25

Top Midday Gainers

MT Newswires Live

BRIEF-Gelteq Begins Preclinical Trial for Novel Gel-Based Antihistamine Targeting Allergy Market

Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market

THOMSON REUTERS

Gelteq Ltd - Plans Human Trials for FDA Approval

THOMSON REUTERS

Healthy Extracts Inc. Reports Record Q2 2025 Sales, Achieves Nearly $100K Adjusted EBITDA with 34% Net Revenue Growth Maintained for Year

Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities

IDT Australia Signs Manufacturing Facility Deal for Gelteq's Products

MT Newswires Live

BUZZ-IDT Australia rises on MoU with US-based drug-delivery platform

BRIEF-IDT Australia Says Co Signs Agreement For Manufacturing Facility

Gelteq Ltd. Reports No Significant Variation in Sales or Net Income; Focus Remains on Research and Expansion Efforts

Top Midday Gainers

MT Newswires Live

BRIEF-Gelteq Expands US Operations With Healthy Extracts As North American Fulfillment Partner

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GELS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GELS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GELS\",,,,,undefined,":{"symbol":"GELS","market":"US","secType":"STK","nameCN":"Gelteq","latestPrice":1.56,"timestamp":1757361600000,"preClose":1.56,"halted":0,"volume":1679521,"hourTrading":{"tag":"盘后","latestPrice":1.48,"preClose":1.56,"latestTime":"19:52 EDT","volume":38420,"amount":59168.7652,"timestamp":1757375556087},"delay":0,"floatShares":4638700,"shares":10028025,"eps":-0.381907,"marketStatus":"Closed","change":0,"latestTime":"09-08 16:00:00 EDT","open":1.29,"high":1.615,"low":1.22,"amount":2306157.003184,"amplitude":0.253205,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.381907,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1757404800000},"marketStatusCode":5,"adr":0,"listingDate":1710129600000,"exchange":"NASDAQ","adjPreClose":1.56,"preHourTrading":{"tag":"盘前","latestPrice":1.3,"preClose":1.56,"latestTime":"09:29 EDT","volume":135766,"amount":181945.1485548,"timestamp":1757338199079},"postHourTrading":{"tag":"盘后","latestPrice":1.48,"preClose":1.56,"latestTime":"19:52 EDT","volume":38420,"amount":59168.7652,"timestamp":1757375556087},"volumeRatio":0.115355},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GELS\",,,,,undefined,":{"symbol":"GELS","floatShares":4638700,"roa":"-8.04%","roe":"-21.00%","lyrEps":-0.291451,"volumeRatio":0.115355,"shares":10028025,"dividePrice":0,"high":1.615,"amplitude":0.253205,"preClose":1.56,"low":1.22,"week52Low":0.7701,"pbRate":"1.26","psRate":"62.76","week52High":5.5,"institutionHeld":0,"latestPrice":1.56,"eps":-0.381907,"divideRate":0,"volume":1679521,"delay":0,"ttmEps":-0.381907,"open":1.29,"prevYearClose":2.32,"prevWeekClose":1.56,"prevMonthClose":1.252,"prevQuarterClose":1.73,"fiveDayClose":1.252,"twentyDayClose":1.66,"sixtyDayClose":2.34},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GELS\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GELS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GELS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GELS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GELS","date":"2025-09-05","current":-2.756963,"percent":1,"low":-21.180883,"twenty":-9.901373,"median":-6.99216,"eighty":-4.681949,"high":-2.756963,"avg":-7.577853,"sd":3.35514,"marketCap":9265057},"quantilePoints":[{"date":"2024-10-24","current":-21.171054,"twenty":-21.176952,"median":-21.171054,"eighty":-21.074172,"marketCap":47190375},{"date":"2024-10-31","current":-10.143847,"twenty":-21.171054,"median":-19.0715,"eighty":-12.552606,"marketCap":22364462},{"date":"2024-11-08","current":-9.685721,"twenty":-21.009583,"median":-10.835689,"eighty":-10.558646,"marketCap":21707572},{"date":"2024-11-15","current":-7.014552,"twenty":-17.133417,"median":-10.60161,"eighty":-9.685721,"marketCap":15289681},{"date":"2024-11-22","current":-6.416922,"twenty":-12.552606,"median":-9.926334,"eighty":-6.79528,"marketCap":14817777},{"date":"2024-11-29","current":-8.190394,"twenty":-11.179072,"median":-9.685721,"eighty":-6.866778,"marketCap":18876150},{"date":"2024-12-06","current":-7.936263,"twenty":-11.904907,"median":-9.791242,"eighty":-6.988572,"marketCap":18122047},{"date":"2024-12-13","current":-12.717639,"twenty":-15.037311,"median":-9.919814,"eighty":-7.370907,"marketCap":28786128},{"date":"2024-12-20","current":-11.5646,"twenty":-14.084739,"median":-10.03509,"eighty":-7.492432,"marketCap":25671564},{"date":"2024-12-27","current":-10.521358,"twenty":-13.396579,"median":-10.430145,"eighty":-7.577881,"marketCap":23217664},{"date":"2025-01-03","current":-10.212771,"twenty":-12.928337,"median":-10.31691,"eighty":-7.75217,"marketCap":22462618},{"date":"2025-01-10","current":-10.447375,"twenty":-12.684632,"median":-10.31691,"eighty":-7.987089,"marketCap":22934522},{"date":"2025-01-17","current":-9.200073,"twenty":-12.390681,"median":-10.143847,"eighty":-8.199443,"marketCap":20291861},{"date":"2025-01-24","current":-12.250467,"twenty":-12.250467,"median":-10.143847,"eighty":-8.235639,"marketCap":27276036},{"date":"2025-01-31","current":-10.587756,"twenty":-11.945486,"median":-10.357767,"eighty":-8.242559,"marketCap":23406426},{"date":"2025-02-07","current":-9.613276,"twenty":-11.838374,"median":-10.143847,"eighty":-8.385479,"marketCap":21424430},{"date":"2025-02-14","current":-9.335065,"twenty":-11.742982,"median":-9.930432,"eighty":-8.685186,"marketCap":20858145},{"date":"2025-02-21","current":-7.993593,"twenty":-11.740961,"median":-9.908289,"eighty":-8.625245,"marketCap":18121104},{"date":"2025-02-28","current":-7.747281,"twenty":-11.599771,"median":-9.805823,"eighty":-8.159414,"marketCap":17177296},{"date":"2025-03-07","current":-5.562716,"twenty":-11.549627,"median":-9.695809,"eighty":-7.723713,"marketCap":12552639},{"date":"2025-03-14","current":-5.584478,"twenty":-11.472534,"median":-9.668507,"eighty":-7.362691,"marketCap":12458259},{"date":"2025-03-21","current":-4.149201,"twenty":-11.277341,"median":-9.487625,"eighty":-6.968767,"marketCap":9261582},{"date":"2025-03-28","current":-4.577543,"twenty":-11.093076,"median":-9.44388,"eighty":-6.473516,"marketCap":10242198},{"date":"2025-04-04","current":-3.851321,"twenty":-10.880164,"median":-9.282379,"eighty":-6.008181,"marketCap":8683029},{"date":"2025-04-11","current":-3.89689,"twenty":-10.716997,"median":-9.200073,"eighty":-5.580126,"marketCap":8588648},{"date":"2025-04-17","current":-3.646379,"twenty":-10.661675,"median":-8.819833,"eighty":-5.383561,"marketCap":8249821},{"date":"2025-04-25","current":-9.652752,"twenty":-10.74667,"median":-8.869441,"eighty":-5.247315,"marketCap":21896334},{"date":"2025-05-02","current":-7.750229,"twenty":-10.661675,"median":-8.814953,"eighty":-5.383561,"marketCap":17554819},{"date":"2025-05-09","current":-6.139277,"twenty":-10.630285,"median":-8.735518,"eighty":-5.474378,"marketCap":13968351},{"date":"2025-05-16","current":-6.99216,"twenty":-10.600957,"median":-8.610931,"eighty":-5.545986,"marketCap":15855966},{"date":"2025-05-23","current":-7.675573,"twenty":-10.57029,"median":-8.239099,"eighty":-5.575773,"marketCap":17460438},{"date":"2025-05-30","current":-6.938057,"twenty":-10.543731,"median":-8.112944,"eighty":-5.636827,"marketCap":15855966},{"date":"2025-06-06","current":-6.975935,"twenty":-10.504597,"median":-7.936263,"eighty":-5.717132,"marketCap":16139108},{"date":"2025-06-13","current":-9.387733,"twenty":-10.504597,"median":-7.964928,"eighty":-5.73826,"marketCap":21707572},{"date":"2025-06-20","current":-7.464332,"twenty":-10.47304,"median":-7.909895,"eighty":-5.7777,"marketCap":17082915},{"date":"2025-06-27","current":-7.644932,"twenty":-10.445748,"median":-7.818055,"eighty":-5.845868,"marketCap":17743581},{"date":"2025-07-03","current":-4.783069,"twenty":-10.439239,"median":-7.807589,"eighty":-5.765943,"marketCap":16233489},{"date":"2025-07-11","current":-5.323861,"twenty":-10.42105,"median":-7.711427,"eighty":-5.562716,"marketCap":18047560},{"date":"2025-07-18","current":-5.389902,"twenty":-10.294483,"median":-7.629441,"eighty":-5.389902,"marketCap":18047560},{"date":"2025-07-25","current":-5.289267,"twenty":-10.212771,"median":-7.530155,"eighty":-5.323861,"marketCap":18047560},{"date":"2025-08-01","current":-5.027113,"twenty":-10.143847,"median":-7.464332,"eighty":-5.289267,"marketCap":16696406},{"date":"2025-08-08","current":-4.542521,"twenty":-9.955308,"median":-7.44921,"eighty":-5.176129,"marketCap":15248741},{"date":"2025-08-15","current":-4.086764,"twenty":-9.934529,"median":-7.347754,"eighty":-5.027113,"marketCap":13704564},{"date":"2025-08-22","current":-3.666074,"twenty":-9.926334,"median":-7.208578,"eighty":-4.89559,"marketCap":12160388},{"date":"2025-08-29","current":-3.7227,"twenty":-9.919814,"median":-7.014552,"eighty":-4.783069,"marketCap":12546432},{"date":"2025-09-05","current":-2.756963,"twenty":-9.901373,"median":-6.99216,"eighty":-4.681949,"marketCap":9265057}],"updateTime":1757385367650},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GELS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2566655016","title":"3 Penny Stocks to Watch Now, 9/8/25","url":"https://stock-news.laohu8.com/highlight/detail?id=2566655016","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566655016?lang=en_us&edition=fundamental","pubTime":"2025-09-09 08:00","pubTimestamp":1757376000,"startTime":"0","endTime":"0","summary":"Peraso Inc., Twin Vee PowerCats, and Gelteq Ltd. are the 3 Penny Stocks to watch on September 8, 2025, based on TipRanks’ Penny Stoc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/3-penny-stocks-to-watch-now-9-8-25?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/3-penny-stocks-to-watch-now-9-8-25?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","GELS"],"gpt_icon":0},{"id":"2565674115","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2565674115","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565674115?lang=en_us&edition=fundamental","pubTime":"2025-09-06 01:46","pubTimestamp":1757094387,"startTime":"0","endTime":"0","summary":"SINTX Technologies  said Wednesday it published a peer-reviewed study demonstrating that silicon nitride exhibits potent antiviral activity against multiple infectious virus strains, including SARS-CoV-2 and MERS-CoV.Shares surged about 36% as intraday trading volume soared to nearly 1.6 million from a daily average of roughly 746,000.Gelteq  said Friday it plans to commence a preclinical bioequivalence study in September to evaluate its gel-based formulation of a widely used antihistamine for allergy treatment.Shares surged about 64% as intraday trading volume soared to roughly 61.6 million from a daily average of about 1.41 million.Broadcom  posted a \"solid\" fiscal Q3, with a significant boost in orders related to AI infrastructure, Truist Securities said in a note emailed Friday.Broadcom gave several notable AI updates in its recent results, including the addition of a fourth infrastructure customer expected to add $10 billion in sales in H2 of fiscal 2026, ongoing 60% growth from e","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0354030438.USD","LU0672654240.SGD","SG9999003800.SGD","LU0057025933.USD","BK4585","LU0345770308.USD","GELS","LU1242518857.USD","LU1917777945.USD","LU2430703095.HKD","LU0719512351.SGD","LU1670627923.USD","LU0476273544.USD","IE00BJTD4V19.USD","BK4598","LU2237957811.SGD","LU2247934214.USD","LU1551013342.USD","SINT","LU0345769128.USD","LU1323610961.USD","LU1935042215.USD","LU2265009873.SGD","IE00BZ1G4Q59.USD","LU0203202063.USD","LU0965509010.AUD","AVGO","IE00B5949003.HKD","SG9999015952.SGD","LU2750360641.GBP","LU0545039389.USD","LU2125154778.USD","LU2322448957.HKD","LU2168564149.EUR","LU1852331112.SGD","LU0444971666.USD","LU1145028129.USD","LU0320765646.SGD","LU2347655156.SGD","IE0004445239.USD","LU2168564222.USD","IE00B7KXQ091.USD","IE00BVYPNW00.USD","LU2487616109.SGD","LU0683600562.USD","LU0210536198.USD","LU2242650005.HKD","LU0444973449.USD","LU1803068979.SGD","LU0964807845.USD"],"gpt_icon":0},{"id":"2565856103","title":"BRIEF-Gelteq Begins Preclinical Trial for Novel Gel-Based Antihistamine Targeting Allergy Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2565856103","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565856103?lang=en_us&edition=fundamental","pubTime":"2025-09-05 23:31","pubTimestamp":1757086317,"startTime":"0","endTime":"0","summary":"BRIEF-Gelteq Begins Preclinical Trial for Novel Gel-Based Antihistamine Targeting Allergy MarketSept 5 (Reuters) - Gelteq Ltd GELS.O:GELTEQ ANNOUNCES COMMENCEMENT OF PRECLINICAL TRIAL FOR NOVEL GEL-BA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250905:nFWN3UR1GL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GELS","BK4007"],"gpt_icon":0},{"id":"2565561753","title":"Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2565561753","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565561753?lang=en_us&edition=fundamental","pubTime":"2025-09-05 23:27","pubTimestamp":1757086031,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250905:nFWN3UR1GL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GELS","BK4007"],"gpt_icon":0},{"id":"2565561737","title":"Gelteq Ltd - Plans Human Trials for FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2565561737","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565561737?lang=en_us&edition=fundamental","pubTime":"2025-09-05 23:27","pubTimestamp":1757086031,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250905:nFWN3UR1GL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","GELS"],"gpt_icon":0},{"id":"2553255463","title":"Healthy Extracts Inc. Reports Record Q2 2025 Sales, Achieves Nearly $100K Adjusted EBITDA with 34% Net Revenue Growth Maintained for Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2553255463","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553255463?lang=en_us&edition=fundamental","pubTime":"2025-07-22 20:35","pubTimestamp":1753187720,"startTime":"0","endTime":"0","summary":"Healthy Extracts Inc. Reports Record Q2 2025 Sales, Achieves Nearly $100K Adjusted EBITDA with 34% Net Revenue Growth Maintained for Year. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthy Extracts Inc. published the original content used to generate this news brief via ACCESS Newswire  on July 22, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250722:nNDL6byG76:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HYEX","GELS"],"gpt_icon":0},{"id":"2552481357","title":"Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2552481357","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552481357?lang=en_us&edition=fundamental","pubTime":"2025-07-17 20:30","pubTimestamp":1752755400,"startTime":"0","endTime":"0","summary":"Partnership to support the scale-up and commercialization of Gelteq’s proprietary gel-based oral delivery platformNEW YORK, July  17, 2025  (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/17/3117209/0/en/Gelteq-Announces-Agreement-with-IDT-Australia-to-Secure-Dedicated-New-Product-Development-and-Manufacturing-Facilities.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDT","API","GELS","BK4535","BK4503","BK4115","BK4023","BK4551","BK4007"],"gpt_icon":0},{"id":"2552109124","title":"IDT Australia Signs Manufacturing Facility Deal for Gelteq's Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2552109124","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552109124?lang=en_us&edition=fundamental","pubTime":"2025-07-17 15:39","pubTimestamp":1752737961,"startTime":"0","endTime":"0","summary":"IDT Australia  signed a memorandum of understanding with Gelteq for an Australian-based manufacturing facility to support the development and scale-up of the Nasdaq-listed firm's gel-based products, according to a Thursday Australian bourse filing.The agreement establishes a framework for Gelteq to develop a dedicated facility within IDT's manufacturing site. It provides facilities and equipment required for the manufacture of the products in a dedicated building and purpose-built facility funded by Gelteq, with trained staff and operational support.The firms anticipate a final binding agreement to be in place in the coming months.The firm's shares rose over 5% in recent trading on Thursday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XJO.AU","XKO.AU","BK7501","GELS","BK4007","XAO.AU","IDT.AU","BK7096","IDT","BK4115"],"gpt_icon":0},{"id":"2552817776","title":"BUZZ-IDT Australia rises on MoU with US-based drug-delivery platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2552817776","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552817776?lang=en_us&edition=fundamental","pubTime":"2025-07-17 11:50","pubTimestamp":1752724243,"startTime":"0","endTime":"0","summary":"BUZZ-IDT Australia rises on MoU with US-based drug-delivery platform** Shares of IDT Australia IDT.AX rise as much as nearly 16% to A$0.11, their highest level since June 10** Stock last up about 5%** Pharma company signs MoU with U.S.-based Gelteq GELS.O to set up manufacturing unit in Australia** Trading volume at around 277,900 shares, 2x 30-day avg** Session trims YTD losses to 9%  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nL4N3TE073:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GELS","IDT.AU","BK7096","BK4007","BK7501"],"gpt_icon":0},{"id":"2552179204","title":"BRIEF-IDT Australia Says Co Signs Agreement For Manufacturing Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2552179204","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552179204?lang=en_us&edition=fundamental","pubTime":"2025-07-17 09:07","pubTimestamp":1752714476,"startTime":"0","endTime":"0","summary":"BRIEF-IDT Australia Says Co Signs Agreement For Manufacturing FacilityJuly 17 (Reuters) - Gelteq GELS.O:SIGNS AGREEMENT TO ESTABLISH DEDICATED PRODUCT DEVELOPMENT & MANUFACTURING FACILITYFurther company coverage: GELS.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nFWN3TD148:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","BK7501","GELS","IDT.AU","BK4007"],"gpt_icon":0},{"id":"2548010988","title":"Gelteq Ltd. Reports No Significant Variation in Sales or Net Income; Focus Remains on Research and Expansion Efforts","url":"https://stock-news.laohu8.com/highlight/detail?id=2548010988","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548010988?lang=en_us&edition=fundamental","pubTime":"2025-07-01 04:21","pubTimestamp":1751314912,"startTime":"0","endTime":"0","summary":"Gelteq Ltd., an Australian public limited company focused on clinical and science-based developments, has released its financial results for the six months ended December 31, 2024. The company has emphasized a substantial advertising budget for the financial year ending June 30, 2026, aimed at introducing its business, products, and services to potential licensees. This initiative will involve increased sales staff, participation in relevant exhibitions and conferences, and traditional online advertising and marketing efforts. Additionally, Gelteq plans to launch a series of mini websites to educate and serve as resource materials for existing and potential customers, potentially increasing sales and initiating more targeted marketing activities. The company has also indicated that if sales volumes or growth opportunities are lower than expected, it may need to explore additional financing options to continue its growth and achieve positive cash flow. Gelteq intends to adjust expenses ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDL5KLbSS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GELS"],"gpt_icon":0},{"id":"2542183344","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2542183344","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542183344?lang=en_us&edition=fundamental","pubTime":"2025-06-11 02:28","pubTimestamp":1749580132,"startTime":"0","endTime":"0","summary":"Arrive AI  disclosed Tuesday the issuance of a new US patent for an artificial intelligence-based platform, expanding its capabilities by enabling temperature-controlled heating and cooling for precision handling.Shares nearly doubled as intraday trading volume catapulted to over 36.2 million from a daily average of about 354,000.Evogene  reported Tuesday the completion of its generative AI foundation model for small molecule design, developed in collaboration with Google Cloud, part of Alphabet .Shares soared 95% as intraday trading volume soared to over 93.7 million from a daily average of roughly 374,000.Gelteq  reported Tuesday the expansion of its US commercial strategy via an exclusive logistics and distribution agreement with Healthy Extracts, a firm focused on producing plant-based health supplements.Shares jumped 60% as intraday trading volume advanced to more than 72.4 million from a daily average of about 1.5 million.Price: 12.53, Change: +6.24, Percent Change: +99.05","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2491050071.SGD","LU0068578508.USD","BK4525","LU1548497426.USD","EVGN.AU","USJW.SI","GELS","LU0314104364.USD","LU1720051017.SGD","LU0708994859.HKD","LU0079474960.USD","LU0096362180.USD","LU1127390331.HKD","EVGN","ARAI","LU0354030511.USD","LU2028103732.USD","LU0320765059.SGD","IE00B1XK9C88.USD","LU0724617625.USD","LU2602419157.SGD","BK4538","LU0094547139.USD","LU0476273544.USD","LU2505996681.GBP","LU0187121727.USD","LU0965508806.USD","IE0034235303.USD","LU2125154935.USD","LU1037948541.HKD","LU2750360641.GBP","BK4588","LU0965509283.SGD","LU1145028129.USD","SG9999018857.SGD","GB00B4QBRK32.GBP","LU1037948897.HKD","LU1935043536.SGD","LU2404859741.USD","LU0965509010.AUD","LU0234570918.USD","BK4561","LU0154236417.USD","LU2054465674.USD","LU2750360997.AUD","BK7095","IE00BFSS7M15.SGD","SGXZ81514606.USD"],"gpt_icon":1},{"id":"2542314526","title":"BRIEF-Gelteq Expands US Operations With Healthy Extracts As North American Fulfillment Partner","url":"https://stock-news.laohu8.com/highlight/detail?id=2542314526","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542314526?lang=en_us&edition=fundamental","pubTime":"2025-06-10 20:27","pubTimestamp":1749558466,"startTime":"0","endTime":"0","summary":"BRIEF-Gelteq Expands US Operations With Healthy Extracts As North American Fulfillment PartnerJune 10 (Reuters) - Gelteq Ltd GELS.O:GELTEQ EXPANDS U.S. OPERATIONS WITH HEALTHY EXTRACTS INC. AS NORTH A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nFWN3SC0OR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GELS","HYEX"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}]}}